Hormone therapies like Zoladex or Prostap are commonly used for prostate cancer to lower the levels of testosterone in the body. Testosterone is a hormone that can stimulate the growth of prostate cancer cells. By decreasing testosterone levels, these therapies help slow down and hopefully stop the growth of cancer cells and can decrease the size of the prostate tumor.
As a result of hormone therapy, PSA (prostate-specific antigen) levels are expected to decrease significantly. PSA is a protein produced by both normal and cancerous prostate cells. When prostate cancer is present, PSA levels are usually increased. Hormone therapy works to decrease the proliferation of prostate cancer cells, leading to a decrease in PSA production.
And although hormone therapy can effectively lower PSA levels, it is not a cure for prostate cancer. Regular monitoring of PSA levels is still necessary to track the progression of the disease and assess the effectiveness of treatment. A decrease in PSA levels while on hormone therapy may indicate a positive response to treatment, but it does not necessarily mean that the cancer has been completely eradicated.
Hormone therapies can aid in reducing PSA levels in prostate cancer patients by lowering testosterone levels and slowing down the growth of cancer cells. But regular monitoring of PSA levels is essential to observe the response to this treatment and make better diagnosis about the next steps in managing the disease.
#testosterone #manhoodtreatment #manhood massage #erectile dysfunction #manhoodtreatment #lingamtherapy
Leave a Reply